It may offer neuroprotective, angiogenic, wound healing and tissue growth propertiesand all of these benefits have been noted in preclinical studies, although human research is severely lacking
According to the FDA-approved prescribing information for Wegovy (semaglutide, current label on file with the FDA as of 2026) and Zepbound (tirzepatide, current label on file with the FDA as of 2026), both carry these warnings: A boxed warning - the FDA's most serious warning category - for thyroid C-cell tumors observed in rodent studies
In clinical trials and other studies, those drugs outperform liraglutide, producing substantially more weight loss while causing fewer side effects
Knockdown of brain-derived neurotrophic factor in specific brain sites precipitates behaviors associated with depression and reduces neurogenesis
adult population suffering from obesity, one might think that is a drop in the bucket
By setting expectations clearly, we prevent disappointment and build motivation early in the process